Photo Rounds

Fever, abdominal pain, and adnexal mass

Author and Disclosure Information

 

References

The following criteria enhance specificity and support the diagnosis5:

  • oral temperature > 101°F (> 38.3°C),
  • abnormal cervical mucopurulent discharge or cervical friability,
  • presence of “abundant numbers of white blood cells on saline microscopy of vaginal fluid,”
  • elevated erythrocyte sedimentation rate (reference range, 0–20 mm/hr),
  • elevated C-reactive protein (reference range, 0.08-3.1 mg/L), and
  • laboratory documentation of cervical infection with N gonorrhoeae or C trachomatis.

The CDC also suggests that the most specific criteria for PID include5

  • endometrial biopsy consistent with endometritis,
  • imaging (transvaginal ultrasound or magnetic resonance imaging) demonstrating fluid-filled tubes, or
  • laparoscopic findings consistent with PID.

Treatment of PID includes IV antibiotics

Due to the polymicrobial nature of PID, antibiotics should cover not only gonorrhea and chlamydia but also anaerobic pathogens. CDC guidelines recommend the following treatment5,6:

  • intravenous (IV) cefotetan (2 g bid) plus doxycycline (100 mg PO or IV bid),
  • IV cefoxitin (2 g qid) plus doxycycline (100 mg PO or IV bid), or
  • IV clindamycin (900 mg tid) plus IV or intramuscular (IM) gentamicin loading dose (2 mg/kg) followed by a maintenance dose (1.5 mg/kg tid).

In mild-to-moderate PID cases deemed appropriate for outpatient therapy, the following regimens have been shown to have similar outcomes to IV therapy5,6:

  • IM ceftriaxone (250 mg, single dose) plus PO doxycycline (100 mg bid) for 14 days with/without PO metronidazole (500 mg bid) for 14 days,
  • IM cefoxitin (2 g, single dose) and PO probenecid (1 g, single dose) plus PO doxycycline (100 mg bid) for 14 days with/without PO metronidazole (500 mg bid) for 14 days, or
  • other parenteral third-generation cephalosporin plus PO doxycycline (100 mg bid) for 14 days with/without PO metronidazole (500 mg bid) for 14 days.

Management in older women may be more intensive

Due to the increased risk of malignancy in postmenopausal women with TOA, surgical intervention may be needed.3,4

Continue to: Our patient

Pages

Recommended Reading

Genetic risk score may flag post-GDM incidence of type 2 disease
MDedge Family Medicine
Macrolides early in pregnancy linked to greater malformation risk
MDedge Family Medicine
Osteoporosis, fracture risk higher in patients with IBD
MDedge Family Medicine
Community-wide initiative ups teen LARC adoption sixfold
MDedge Family Medicine
Preterm birth: Under the microscope
MDedge Family Medicine
Understanding the cervicovaginal microbiome and how it affects preterm birth
MDedge Family Medicine
Abbreviated MRI bests digital breast tomosynthesis in finding cancer in dense breasts
MDedge Family Medicine
Endocrine Society advises on use of romosozumab for osteoporosis
MDedge Family Medicine
In gestational diabetes, early postpartum glucose testing is a winner
MDedge Family Medicine
New guideline offers recommendations for reproductive health in patients with rheumatic diseases
MDedge Family Medicine